Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27(Kip1)

被引:224
|
作者
CasacciaBonnefil, P
Tikoo, R
Kiyokawa, H
Friedrich, V
Chao, MV
Koff, A
机构
[1] MEM SLOAN KETTERING CANC CTR,PROGRAM MOL BIOL,NEW YORK,NY 10021
[2] CORNELL UNIV,COLL MED,DEPT ANAT & CELL BIOL,NEW YORK,NY 10021
[3] CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021
[4] CUNY MT SINAI SCH MED,BROOKDALE CTR MOL BIOL,NEW YORK,NY 10029
关键词
oligodendrocyte progenitor cells; cell proliferation; differentiation; CKI p27(Kip1);
D O I
10.1101/gad.11.18.2335
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During development of the central nervous system, oligodendrocyte progenitor cells (O-2A) undergo an orderly pattern of cell proliferation and differentiation, culminating in the ability of oligodendrocytes to myelinate axons. Here we report that p27(Kip1), a cyclin-dependent kinase inhibitor, is an important component of the decision of O-2A cells to withdraw from the cell cycle. In vitro, accumulation of p27 correlates with differentiation of oligodendrocytes. Furthermore, only a fraction of O-2A cells derived from p27-knockout mice differentiate successfully compared to controls. Inability to differentiate correlates with continued proliferation, suggesting that p27 is an important component of the machinery required for the G(1)/G(0) transition in O-2A cells. In vivo, expansion of O-2A precursors before withdrawal, in part, leads to a greater number of oligodendrocytes. Together these data indicate a role for p27 during the decision to withdraw from the cell cycle in the oligodendrocyte lineage.
引用
收藏
页码:2335 / 2346
页数:12
相关论文
共 50 条
  • [31] Angiotensin II (A II) stimulates induction of the cyclin-dependent kinase inhibitor p27(Kip1) in LLC-PK1 cells.
    Wolf, G
    Schroeder, R
    Stahl, RAK
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2102 - A2102
  • [32] Expression of the cyclin-dependent kinase inhibitor p27 in leukemias
    Petrucci, MT
    Gregorj, C
    Ariola, C
    Ricciardi, MR
    Mercurio, C
    Dominguez, JE
    Draetta, G
    Tafuri, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 29 - 29
  • [33] Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma
    Hu, WM
    Cook, T
    Oh, CW
    Penneys, NS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) : 473 - 475
  • [34] Crystal structure of the p27(Kip1) cyclin-dependent-kinase inhibitor bound to the cyclin A Cdk2 complex
    Russo, AA
    Jeffrey, PD
    Patten, AK
    Massague, J
    Pavletich, NP
    [J]. NATURE, 1996, 382 (6589) : 325 - 331
  • [35] Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
    Hiromura, K
    Pippin, JW
    Fero, ML
    Roberts, JM
    Shankland, SJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 597 - 604
  • [36] Modulation of the p27(kip1) cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation
    Blanchard, DA
    Affredou, MT
    Vazquez, A
    [J]. JOURNAL OF IMMUNOLOGY, 1997, 158 (07): : 3054 - 3061
  • [37] Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27(Kip1)
    Wolf, G
    Stahl, RAK
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (06) : 2112 - 2119
  • [38] Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
    Vlach, J
    Hennecke, S
    Amati, B
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 26 - 26
  • [39] Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter
    Zhang, Y
    Lin, SC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1353 (03): : 307 - 317
  • [40] Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
    A Alessandrini
    DS Chiaur
    M Pagano
    [J]. Leukemia, 1997, 11 : 342 - 345